Home / Specialties / Pediatrics / Silva A. Arslanian, MD, Q1: T2DM in Children – Earlier co-morbidities?

Silva A. Arslanian, MD, Q1: T2DM in Children – Earlier co-morbidities?

Dr. Arslanian talks about the earlier incidence rate of ESRD of people who have type 2 in childhood as well as her own team’s studies on cardiovascular markers, and the premature “aging” of the CV system seen in these individuals. She also discusses the challenges of children growing up in families where type 2 is so prevalent it seems inevitable, and the necessity of a major societal change in order to affect this.

More videos with Dr. Arslanian:

Silva A. Arslanian, MD, Introduction

What drugs can be prescribed to children with diabetes?

How does the drug approval process differ for children?

Disparities in diabetes rates between children of different socio-economic class

Difficulties of Educating Parents

Silva A. Arslanian, MD, is Chief, Weight Management and Wellness Center; Director, Pediatric Clinical and Translational Research Center; UPMC Richard L. Day Endowed Chair in Pediatrics; and Professor of Pediatrics, University of Pittsburgh School of Medicine. She attended medical school at the American University of Beirut School of Medicine, Beirut, Lebanon; did her residency at the American University Hospital of Beirut, Beirut, Lebanon; and fellowship at Children’s Hospital of Pittsburgh of UPMC, Pittsburgh, PA.